Bionx Implants, Inc. v. Innovasive Devices, Inc.

45 F. Supp. 2d 75, 1999 U.S. Dist. LEXIS 3697, 1999 WL 171312
CourtDistrict Court, D. Massachusetts
DecidedMarch 16, 1999
DocketCIV. A. 98-12111-NG
StatusPublished
Cited by1 cases

This text of 45 F. Supp. 2d 75 (Bionx Implants, Inc. v. Innovasive Devices, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bionx Implants, Inc. v. Innovasive Devices, Inc., 45 F. Supp. 2d 75, 1999 U.S. Dist. LEXIS 3697, 1999 WL 171312 (D. Mass. 1999).

Opinion

MEMORANDUM AND ORDER

GERTNER, District Judge.

Plaintiffs, Bionx Implants; Inc., Bionx Implants, Oy, and Dr. Saul N. Schreiber (“Bionx”), seek a Preliminary Injunction enjoining defendant Innovasive Devices, Inc. (“Innovasive”) from the manufacture, use, offering for sale, sale or importation of the Innovasive Dart (“Dart”), a product that Bionx claims literally infringes its Patent, No. 4,873,976 (“the Schreiber patent”). Primarily because I hold, for reasons explained below, that Bionx is unlike *76 ly to succeed on the merits, Bionx’s Motion for a Preliminary Injunction (docket #3) is DENIED.

I. FACTUAL BACKGROUND

A. The Devices

The Schreiber patent is for a “surgical fastener and method,” using a bioabsorba-ble device for repairing torn body tissues, especially a torn meniscus in the knee. The device is called a Meniscus Arrow (“Arrow”). In simpler language, the Arrow is essentially a barbed, bioabsorbable nail. See Appendix, figures 3-7. It is driven into a torn meniscus, and holds the meniscus together to allow healing to take place. The meniscus is held together because one or more barbs in the device prevent it from sliding out, and the base keeps it from sliding further in. The torn meniscus is therefore squeezed together between the barb or barbs and the base.

The Dart serves the same function. It too is a bioabsorbable suture that holds a torn meniscus together so that it can heal. Its configuration, however, is less like a conventional nail. See Appendix. The tip is rather blunt, and coming off the shaft on only one side, are two or three fins. These fins function like the barb or barbs on the Arrow. Some distance below the fins, a gusset or ridge runs down the side of the shaft. At the tail end of the shaft, on the same side as the fins and gusset, a bar sits angled slightly forward towards the tip. The bar serves the same function as the base on the Arrow.

B. The Infringement Claim

Bionx says that the Dart literally infringes on Claims 1 and 15 of the Schreiber patent because it embodies each element of those Claims. (While Bionx’s Complaint says that the Dart infringes the Schreiber patent “literally and/or under the doctrine of equivalents,” the preliminary injunction motion is based solely on the grounds of literal infringement.) Claim 1, describing “A single unit suture for body tissue repair,” has the following elements:

(a) a solid base member for seating against an exterior surface of said tissue;
(b) a single rigid shaft portion upstanding from and integrally connected to said base member adapted for insertion into said tissue; and
(c) barb means integrally connected to said shaft portion to aid in insertion of said shaft portion into said tissue and to lock said shaft portion into said tissue.

Claim 15 has the same elements, but adds that the suture is resorbable in tissue.

II. LEGAL STANDARDS

The standard for obtaining a preliminary injunction is the same in a patent case as it is in other cases. As the moving party, Bionx has to establish its right to a preliminary injunction based on four factors: “(1) a reasonable likelihood of success on the merits; (2) irreparable harm if the injunction were not granted; (3) the balance of relative hardships tips in its favor; and (4) whether and how an injunction would impact the public interest.” Bell and Howell Document Management v. Altek Sys., 132 F.3d 701, 705 (Fed.Cir.1997).

The core of the analysis concerns Bionx’s likelihood of success on the merits. There are two steps in determining whether there has been a literal infringement: “The first step is determining the meaning and scope of the patent claims asserted to be infringed. The second step is comparing the properly construed claims to the device accused of infringing.” Markman v. Westview Instruments, Inc., 52 F.3d 967, 976 (Fed.Cir.1995) aff'd, 517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996) (citation omitted). The first step, that of claim construction, is exclusively a question of law for a court to decide. Markman, 517 U.S. at 372, 116 S.Ct. 1384.

*77 Bionx has the burden of proving infringement. Glaxo, Inc. v. Novopharm, Ltd., 110 F.3d 1562, 1567 (Fed.Cir.1997). In order to establish literal infringement of Claim 1, Bionx must demonstrate that the accused device, the Dart, “embodies] every element of’ Claim 1. 1 Mannesmann Demag Corp. v. Engineered Metal Prods. Co., 793 F.2d 1279, 1282 (Fed.Cir.1986). See also Strattec Security Corp. v. General Automotive Specialty Co., Inc., 126 F.3d 1411, 1418 (Fed.Cir.1997).

[3] Before determining whether the Dart infringes on every element of Claim 1, I must construe the elements of Claim 1. “It is well-settled that, in interpreting an asserted claim, the court should look first to the intrinsic evidence of record, i.e. the patent itself, including the claims, the specification and, if in the evidence, the procedural history.” Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed.Cir.1996). In this case, I have no need to go beyond the intrinsic evidence.

III. ANALYSIS

A. Success on the Merits

1. Construing the Claim

I find that the Dart does not infringe the third element of Claim 1. As such, I conclude that the Dart does not literally infringe on either Claim 1 or Claim 15 of the Sehreiber patent.

The third element of Claim 1 reads, “barb means integrally connected to said shaft portion to aid in insertion of said shaft portion into said tissue and to lock said shaft portion into said tissue” (emphasis added). 2

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amirentezam v. Islamic Republic of Iran
District of Columbia, 2023

Cite This Page — Counsel Stack

Bluebook (online)
45 F. Supp. 2d 75, 1999 U.S. Dist. LEXIS 3697, 1999 WL 171312, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bionx-implants-inc-v-innovasive-devices-inc-mad-1999.